AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow CME/SAM
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabourin, S. M.
Right arrow Articles by Mullins, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabourin, S. M.
Right arrow Articles by Mullins, M. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.7094
AJR 2008; 191:S28-S30
© American Roentgen Ray Society

Imaging of Osteosarcoma After Irradiation: Self-Assessment Module

Stephen M. Sabourin1, Ashok Jayashankar and Mark E. Mullins

1 All authors: Department of Radiology, Emory University Hospital, 1364 Clifton Rd. NE, Rm. D125A, Atlanta, GA 30322.

Received April 25, 2008; accepted after revision April 25, 2008.

 
Address correspondence to S. M. Sabourin (ssabour{at}emory.edu).


Abstract
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
The educational objectives of this self-assessment module on the imaging of postirradiation osteosarcoma are for the participant to exercise, self-assess, and improve his or her understanding of the features used to establish the diagnosis of postirradiation sarcoma.

Keywords: head and neck imaging • postirradiation • oncology • osteosarcoma


INTRODUCTION
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
This self-assessment module has an educational component and a self-assessment component. The educational component consists of three required articles that the participant should read and two recommended articles that will provide further perspective and understanding. The self-assessment component consists of five multiple-choice questions with solutions. All of these materials are available on the ARRS Website (www.arrs.org). To claim CME and SAM credit, each participant must enter his or her responses to the questions online.


EDUCATIONAL OBJECTIVES
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
By completing this educational activity, the participant will:

  1. Exercise, self-assess, and improve his or her understanding of the clinical history and radiation treatments that predispose patients to developing postirradiation sarcoma.
  2. Gain familiarity with the varied imaging appearances of bone sarcomas.


REQUIRED READING
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 

  1. Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol 2001; 56:22–29
  2. Lee YY, Tassel PV, Nauert C, Raymond AK, Edeiken J. Craniofacial osteosarcomas: plain film, CT, and MR findings in 46 cases. AJR 1988; 150:1397–1402
  3. Sabourin SM, Jayashankar A, Mullins ME. AJR teaching file: lump on the head. AJR 2008; 191[suppl]:S31–S33


RECOMMENDED READING
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 

  1. Weatherby RP, Dahlin DC, Ivins JC. Post radiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc 1981; 56:294–306
  2. Tateishi U, Hasegawa T, Miyakawa K, Sumi M, Moriyama N. CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma. AJR 2003; 181:879–884


INSTRUCTIONS
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 

  1. Complete the required reading.
  2. Visit www.arrs.org and select Publications/Journals/SAM Articles from the left-hand menu bar.
  3. Using your member login, order the online SAM as directed.
  4. Follow the online instructions for entering your responses to the self-assessment questions and complete the test by answering the questions online.


QUESTION 1 All of the following are TRUE regarding postirradiation sarcoma EXCEPT:

  1. They typically occur at the edge of the radiation field.
  2. They usually develop within a latency period of 2–3 years.
  3. The most common surgical pathology identified is osteosarcoma.
  4. Imaging features of a CT or MR scan are typically indistinguishable from those of spontaneous, de novo sarcoma.
  5. They are unlikely to occur below a previous radiation treatment dose of 10 Gy.

QUESTION 2 Familial retinoblastoma is associated with all of the following second malignant neoplasms EXCEPT:

  1. Melanoma.
  2. Malignant fibrous histiocytoma.
  3. Ewing's sarcoma.
  4. Renal cell carcinoma.
  5. Rhabdomyosarcoma.

QUESTION 3 Clinical syndromes and preexisting bone lesions associated with the development of osteosarcoma include all of the following EXCEPT:

  1. Li-Fraumeni syndrome.
  2. Osteonecrosis.
  3. Achondroplasia.
  4. Werner's syndrome.
  5. Fibrous dysplasia.

QUESTION 4 The most typical radiographic finding of postirradiation osteosarcoma is:

  1. Tumor matrix mineralization.
  2. Periosteal reaction.
  3. Soft-tissue extension of tumor.
  4. Osteoblastic tumor.
  5. Narrow zone of transition.

QUESTION 5 Which of the following is TRUE regarding secondary osteosarcomas?

  1. Secondary osteosarcoma is associated with underlying Paget's disease.
  2. Radical surgical excision is usually not indicated.
  3. Histopathologically, they are typically composed of low-grade neoplastic cells.
  4. The 5- to 10-year survival rate and prognosis are often very good.
  5. Radiologic evidence of the underlying lesion is usually obscured by the malignant process.

 

Solution to Question 1
Lower doses at the periphery of the irradiation portal can result in damage to the reparative mechanisms without cell death, putting these regions at highest risk for malignant transformation [1, 2]. Option A, which is true, is not the best response. To some degree, improved health care has likely contributed to patients who receive radiation therapy living long enough to experience the oncogenic effects of irradiation, and the relative risk of this type of complication increases with time [1, 2]. Approximately 80–90% of postirradiation sarcoma arises in the bone [1, 2]. Option C, which is true, is not the best response. Radiologic imaging features alone cannot distinguish between primary and secondary osteosarcoma. The need for an appropriate clinical and radiation therapy history is thus a necessity [1, 2]. Option D, which is true, is not the best response. Threshold doses have been reported below which postirradiation sarcoma is said to be negligible—that is, less than 10 Gy of radiation [1, 2]. Option E, which is true, is not the best response. Two published case review series of postirradiation sarcomas found a mean latency period of 14.5–15.5 years, a range of 3–65 years after treatment [1, 2]. Option B, which is not true, is the best response.

Solution to Question 2
Familial retinoblastoma is associated with multiple second malignant neoplasms, the most common of which is osteosarcoma. For survivors of bilateral retinoblastoma, it has been suggested that the cumulative lifetime risk of developing a second malignant neoplasm is 32% [3]. Abramson et al. [3] found that in children who had received radiation therapy for bilateral or familial unilateral retinoblastoma, 30% of second malignant neoplasms occurred outside the field of radiation. Other second malignant neoplasms include melanoma, rhabdomyosarcoma, malignant fibrous histiocytoma, Ewing's sarcoma, and brain tumors [47]. Renal cell carcinoma is not regarded as an associated second malignant neoplasm. Option D is the best response.

Solution to Question 3
Many preexisting benign bone lesions and clinical syndromes have been associated with an increased risk for developing osteosarcoma. By far, the most common preexisting lesion is Paget's disease [8]. Other less common preexisting bone lesions include fibrous dysplasia, chronic osteomyelitis, metallic implants, and bone infarction [8]. Options B and E, which are associated, are not the correct responses. The association of familial retinoblastoma with osteosarcoma is well documented [410]. Other less common syndromes include Li-Fraumeni syndrome, Rothmund-Thomson syndrome, and Werner's syndrome [1113]. Options A and D, which are associated, are not the correct responses. Rothmund-Thomson syndrome and Werner's syndrome are a result of faulty helicase proteins that predispose cells to faulty DNA replication [11]. Familial retinoblastoma and Li-Fraumeni syndrome predispose patients to osteosarcoma by way of faulty tumor suppression genes—the retinoblastoma gene on chromosome 13q and p53 on chromosome 17p, respectively [12, 14, 15]. Achondroplasia is not associated with osteosarcoma. Option C, which is not associated, is the best response.

Solution to Question 4
The most typical radiographic finding of secondary osteosarcoma is a soft-tissue extension of the tumor [1, 8, 9]. A study by Lee et al. [9] evaluated the characteristics of 46 de novo and secondary craniofacial osteosarcomas and found that all cases had soft-tissue extension of tumor. Option C is the best response.Their findings also showed tumor matrix mineralization occurs in 75% of cases, with osteoid matrix calcification occurring most frequently [9]. Option A is not the best response. Periosteal reaction is not typically seen; the lesions usually show a long zone of transition [9]. Options B and E are not the best responses. Most postirradiation craniofacial osteosarcomas are osteolytic with the exception of those occurring in the mandible, which can be osteoblastic in approximately 50% of the cases [9]. Option D is not the best response.

Solution to Question 5
Radical surgical excision is usually the only hope for long-term survival [2, 4]. Option B is not the best response. Osteosarcomas are typically composed of high-grade malignant cells and have a poor 5- to 10-year survival rate [8]. Options C and D are not the best responses. Radiographically, an underlying condition in combination with osteosarcoma may be discernable, suggesting sarcomatous malignant transformation [1, 2, 8]. Option E is not the best response. Secondary osteosarcoma transformation has been shown to occur with increased frequency in the setting of underlying pagetoid bone, with a much higher incidence of occurrence in patients with the severe polyostotic form of the disease [8, 16, 17]. Option A is the best response.


References
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 

  1. Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol2001; 56:22 –29[CrossRef][Medline]
  2. Weatherby RP, Dahlin DC, Ivins JC. Post radiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc1981; 56:294 –306[Medline]
  3. Abramson DH, Ellsworth RM, Kitchin, Tung G. Second nonocular tumors in retinoblastoma survivors: are they radiation-induced? Ophthalmology 1984;91 :1351 –1355[Medline]
  4. Chan LL, Czerniak BA, Ginsberg LE. Radiation-induced osteosarcoma after bilateral childhood retinoblastoma. AJR2000; 174:1288[Free Full Text]
  5. Moppett J, Oakhill A, Duncan AW. Second malignancies in children: the usual suspects? Eur J Radiol 2001;37 : 235–248
  6. Vazquez E, Castellote A, Piqueras J, et al. Second malignancies in pediatric patients: imaging findings and differential diagnosis. RadioGraphics 2003;23 :1155 –1172[Abstract/Free Full Text]
  7. Tateishi U, Hasegawa T, Miyakawa K, Sumi M, Moriyama N. CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma. AJR 2003;181 : 879–884[Abstract/Free Full Text]
  8. Murphey MD, Robbin MR, McRae GA, Flemming DJ, Temple HT, Kransdorf MJ. The many faces of osteosarcoma. RadioGraphics1997; 17:1205 –1231[Abstract]
  9. Lee YY, Tassel PV, Nauert C, Raymond AK, Edeiken J. Craniofacial osteosarcomas: plain film, CT, and MR findings in 46 cases. AJR 1988; 150:1397 –1402[Abstract/Free Full Text]
  10. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 1988;95.1583 –1587
  11. Lindor NM, Furuichi Y, Kitao S, Shimamoto A, Arndt C, Jalal S. Rothmund-Thomson syndrome due to RECQ4 helicase mutations: report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome. Am J Med Genet 2000;90 : 223–228[CrossRef][Medline]
  12. Bookstein R, Allred DC. Recessive oncogenes. Cancer 1993;71 [3 suppl]:1179 –1186[CrossRef][Medline]
  13. Varley JM. Germline TP53 mutations and Li–Fraumeni syndrome. Hum Mutat 2003;21 : 313–320[CrossRef][Medline]
  14. Ozisik YY, Meloni AM, Zalupski MM, Ryan JR, Qureshi F, Sandberg AA. Deletion of chromosome 13 in osteosarcoma secondary to irradiation. Cancer Genet Cytogenet 1993;69 : 35–37[CrossRef][Medline]
  15. Mohney BG, Robertson DM, Schomberg PJ, Hodge DO. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol 1998;126 : 269–277[CrossRef][Medline]
  16. Grossman RI, Yousem DM. Neuroradiology: the requisites, 2nd ed. Philadelphia, PA: Elsevier,2003
  17. Resnick D, Niwayama G. Paget disease. In: Resnick D, ed. Diagnosis of bone and joint disorders, 4th ed. Philadelphia, PA: Saunders, 2002:1947 –2000

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow CME/SAM
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabourin, S. M.
Right arrow Articles by Mullins, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabourin, S. M.
Right arrow Articles by Mullins, M. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS